|Study Description:||The goal of this clinical research study is to find the highest tolerable dose |
of WT2725 that can be given to patients with advanced cancer. The safety of
WT2725 will also be studied.
WT2725 is a vaccine designed to help your immune system to fight against the
cancer cells by targeting a protein found in cancer cells called WT1. It is
hoped that this may slow down the growth of or kill cancer cells.